$CNS Cashflow Statement | Understand Stock

$CNS

$70.05 -$0.74 (1.05%) Close

$CNS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Stock compensation expense
Depreciation and amortization
Non-cash lease expense
Amortization (accretion) of premium (discount) on U.S. treasury securities - net
(Gain) loss from investments—net
Deferred income taxes
Foreign currency (gain) loss
Changes in operating assets and liabilities:
Accounts receivable
Due from brokers
Deferred commissions
Investments within consolidated funds
Other assets
Accrued compensation
Distribution and service fees payable
Operating lease liabilities
Due to broker
Income tax payable
Other liabilities and accrued expenses

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchases of investments
Proceeds from sales of investments
Purchases of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Issuance of common stock
Proceeds from issuance of common stock from offering, net of issuance costs
Repurchase of common stock
Dividends to stockholders
Contributions from redeemable noncontrolling interests
Other
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Effect of foreign exchange rate changes on cash and cash equivalents
Cash and cash equivalents, beginning of the year
Cash and cash equivalents, end of the year

Comments